Sanara MedTech Inc. is under investigation by the Schall Law Firm for potential securities law violations after it announced the discontinuation of its Tissue Health Plus program and reported a $31.2 million net loss from discontinued operations, including a $26.5 million charge related to the program. The company's stock dropped 24.7% following the announcement. The investigation focuses on whether Sanara made false or misleading statements or failed to disclose important information to investors. Shareholders who suffered losses are encouraged to contact the law firm to discuss their rights.
TotalEnergies has applied for authorization to build a 1.5 GW offshore wind farm off Normandy, France, marking the country's largest renewable energy project. The €4.5 billion investment aims to generate about 6 TWh annually, enough to power nearly o...
A NordLayer report reveals that 82% of IT professionals experienced web-based security incidents in the past year, with half describing the impact as moderate or severe. Increased use of BYOD policies, remote work, and SaaS tools expands attack surfa...
Citytv has announced the renewal of its popular series Hudson & Rex for a new 12-episode season, with production beginning in June 2026 in St. John's, Newfoundland. John Reardon returns as detective Charlie Hudson, reuniting with his canine partner R...
Citytv has announced the renewal of its popular series Hudson & Rex for a new 12-episode season starting production in June 2026 in St. John's, Newfoundland. John Reardon returns as Detective Charlie Hudson, reuniting with his canine partner Rex, alo...
Medidata unveiled its next-generation AI-powered imaging solution at ASCO 2026, enhancing clinical trial efficiency by speeding up protected health information redaction by 32% and achieving over 97% accuracy in anatomy verification. This technology ...
